Ju Li1, Yan Zhu1. 1. Department of Hematology, Southwest Hospital, Army Medical University, Chongqing 400038, China.
Abstract
BACKGROUND: Hematopoietic stem cell transplantation has been applied to treat the hematologic malignancies since the 1980s. However, allogenic transplantation has inherent complications such as graft-versus-host disease and graft failure. Autologous transplantation has become more and more popular because of its lower transplant-related mortality. This study was performed to analyze the possible prognostic factors for myeloma patients post stem cell transplantation. METHODS: Patients' information was collected by history review and follow-up through the phone call. Kaplan-Meier was used to exhibit overall survival (OS) and progression-free survival (PFS). Univariate and multivariate analyses were performed using Cox proportional hazards model. A P<0.05 is considered statistically significant. RESULTS: Thirty patients with multiple myeloma were included in this study, 7 of them died because of myeloma relapse and myeloma-associated complications. The average survival time was 29.8 months and the median follow-up was 25.1 months. The 1-year OS and PFS were 93.3% and 90.0%, respectively. Both the 3-year OS and PFS were 76.7%. In a variety of factors, improved renal function showed a good effect on the outcome of transplantation. CONCLUSIONS: To prevent cancer relapse after autologous transplantation, it is of great significance to achieve a complete remission prior to the transplantation. 2019 Stem Cell Investigation. All rights reserved.
BACKGROUND: Hematopoietic stem cell transplantation has been applied to treat the hematologic malignancies since the 1980s. However, allogenic transplantation has inherent complications such as graft-versus-host disease and graft failure. Autologous transplantation has become more and more popular because of its lower transplant-related mortality. This study was performed to analyze the possible prognostic factors for myeloma patients post stem cell transplantation. METHODS: Patients' information was collected by history review and follow-up through the phone call. Kaplan-Meier was used to exhibit overall survival (OS) and progression-free survival (PFS). Univariate and multivariate analyses were performed using Cox proportional hazards model. A P<0.05 is considered statistically significant. RESULTS: Thirty patients with multiple myeloma were included in this study, 7 of them died because of myeloma relapse and myeloma-associated complications. The average survival time was 29.8 months and the median follow-up was 25.1 months. The 1-year OS and PFS were 93.3% and 90.0%, respectively. Both the 3-year OS and PFS were 76.7%. In a variety of factors, improved renal function showed a good effect on the outcome of transplantation. CONCLUSIONS: To prevent cancer relapse after autologous transplantation, it is of great significance to achieve a complete remission prior to the transplantation. 2019 Stem Cell Investigation. All rights reserved.
Authors: Shaji K Kumar; Natalie S Callander; Melissa Alsina; Djordje Atanackovic; J Sybil Biermann; Jason C Chandler; Caitlin Costello; Matthew Faiman; Henry C Fung; Cristina Gasparetto; Kelly Godby; Craig Hofmeister; Leona Holmberg; Sarah Holstein; Carol Ann Huff; Adetola Kassim; Michaela Liedtke; Thomas Martin; James Omel; Noopur Raje; Frederic J Reu; Seema Singhal; George Somlo; Keith Stockerl-Goldstein; Steven P Treon; Donna Weber; Joachim Yahalom; Dorothy A Shead; Rashmi Kumar Journal: J Natl Compr Canc Netw Date: 2017-02 Impact factor: 11.908
Authors: Paul G Richardson; Pieter Sonneveld; Michael W Schuster; David Irwin; Edward A Stadtmauer; Thierry Facon; Jean-Luc Harousseau; Dina Ben-Yehuda; Sagar Lonial; Hartmut Goldschmidt; Donna Reece; Jesus F San-Miguel; Joan Bladé; Mario Boccadoro; Jamie Cavenagh; William S Dalton; Anthony L Boral; Dixie L Esseltine; Jane B Porter; David Schenkein; Kenneth C Anderson Journal: N Engl J Med Date: 2005-06-16 Impact factor: 91.245
Authors: Philip R Greipp; Jesus San Miguel; Brian G M Durie; John J Crowley; Bart Barlogie; Joan Bladé; Mario Boccadoro; J Anthony Child; Herve Avet-Loiseau; Jean-Luc Harousseau; Robert A Kyle; Juan J Lahuerta; Heinz Ludwig; Gareth Morgan; Raymond Powles; Kazuyuki Shimizu; Chaim Shustik; Pieter Sonneveld; Patrizia Tosi; Ingemar Turesson; Jan Westin Journal: J Clin Oncol Date: 2005-04-04 Impact factor: 44.544
Authors: K Okada; N Oguchi; K Shinohara; N Tamura; K Ishii; Y Noguchi; S Hayashi; H Yamamoto; M Takeichi; H Fujimoto; T Shirota; T Hayashi Journal: Rinsho Ketsueki Date: 1997-12
Authors: Julie M Vose; Douglas J Rizzo; Jing Tao-Wu; James O Armitage; Asad Bashey; Linda J Burns; Neal Paul Christiansen; Cesar O Freytes; Robert Peter Gale; John Gibson; Sergio A Giralt; Roger H Herzig; Charles F Lemaistre; Philip L McCarthy; Stephen D Nimer; Finn B Petersen; David P Schenkein; Peter H Wiernik; Joseph M Wiley; Fausto R Loberiza; Hillard M Lazarus; Koen van Biesen; Mary M Horowitz Journal: Biol Blood Marrow Transplant Date: 2004-02 Impact factor: 5.742
Authors: Natacha Heutte; Henning H Flechtner; Nicolas Mounier; Wilhelmina A M Mellink; Jacobus H Meerwaldt; Houchingue Eghbali; Mars B van't Veer; Evert M Noordijk; Johanna C Kluin-Nelemans; Elzbieta Lampka; José Thomas; Pieternella J Lugtenburg; Luisa Viterbo; Patrice Carde; Anton Hagenbeek; Richard Wm van der Maazen; Wilma G J M Smit; Pauline Brice; Marinus van Marwijk Kooy; Johanna W Baars; Philip Poortmans; Umberto Tirelli; Onno C Leeksma; Radka Tomsic; Pierre Feugier; Gilles Salles; Jean Gabarre; Marie José Kersten; Eric Van Den Neste; Geert-Jan M Creemers; Isabelle Gaillard; Paul Meijnders; Gérard Tertian; Oumédaly Reman; Hein P Muller; Jacques Troncy; Michel Blanc; Wilfried Schroyens; Paul J Voogt; Pierre Wijermans; Chantal Rieux; Christophe Fermé; Michel Henry-Amar Journal: Lancet Oncol Date: 2009-10-12 Impact factor: 41.316
Authors: Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp Journal: Mayo Clin Proc Date: 2003-01 Impact factor: 7.616
Authors: Jennifer M Knight; Jan A Moynihan; Jeffrey M Lyness; Yinglin Xia; Xin Tu; Susan Messing; Bryan C Hunter; Li-Shan Huang; Rosemary O Obi; D'Arcy Gaisser; Jane L Liesveld; Olle Jane Z Sahler Journal: PLoS One Date: 2014-06-10 Impact factor: 3.240